- Location
Cell Therapeutics
"-
BrainStorm Cell Therapeutics Has Received a Notice of Allowance From The US Patent Office
Feb 11, 2014BrainStorm Cell Therapeutics has received a notice of allowance from the US Patent Office for its ‘Mesenchymal Stem Cells for the Treatment of CNS Diseases’ (serial number 12/994,761) patent application. This patent relates to ...
Tags: Cell Technology Patent, Medicine
-
Transparency Commission of The French National Health Authority Has Granted Market Access
Aug 20, 2013The Transparency Commission of the French National Health Authority has granted market access for Cell Therapeutics' (CTI) aggressive non-hodgkin lymphoma treatment, Pixuvri (pixantrone) in France. Pixuvri is indicated as monotherapy for ...
-
European Commission Has Granted Orphan Drug Designation to BrainStorm NurOwn
Jul 31, 2013The European Commission has granted orphan drug designation to BrainStorm Cell Therapeutics’ stem cell therapy NurOwn to treat Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. NurOwn consists of autologous ...
Tags: Orphan Drug, Medicine
-
AIFA Granted Market Access to Cell Therapeutics for The Medicinal Product
Jul 10, 2013The Italian Medicines Agency (AIFA) has granted market access to Cell Therapeutics for the medicinal product, Pixuvri (pixantrone), a novel aza-anthracenedione with structural and physiochemical properties Pixuvri has been approved as a ...
-
OCS Has Awarded $3m NIS Grant to Support Brainstorm Cell Therapeutics' Research
Dec 17, 2012The Office of the Chief Scientist (OCS) in Israel has awarded $3m NIS grant to support BrainStorm Cell Therapeutics' research and development program for stem cell therapy candidate, NurOwn. NurOwn is an autologous, adult stem cell ...
Tags: stem cell therapy technology, Cell Therapeutics, therapy technology
-
Aequus BioPharma Named Ronald Berenson as The Company's New President and CEO
Dec 11, 2012Aequus BioPharma,a subsidiary of Cell Therapeutics,has named Ronald Berenson as the company's new president and CEO. Prior to joining the company,Berenson served as president and CEO at HemaQuest Pharmaceuticals and as ...
Tags: Aequus BioPharma, Cell Therapeutics, CEO, Ronald Berenson
-
CTI Has Announced The European Launch of Pixuvri for The Treatment of Adult Patients
Nov 29, 2012Cell Therapeutics (CTI) has announced the European launch of Pixuvri for the treatment of adult patients with multiply relapsed or refractory aggressive non-hodgkin B-cell lymphoma. The company initiated the launch with entry into Sweden, ...
Tags: Cell Therapeutics, Pixuvri, NHL, B-cell lymphoma
-
EC Has Awarded a Conditional Marketing Authorization Approval for Cell Therapeutics Pixuv
May 11, 2012The European Commission (EC) has awarded a conditional marketing authorization approval for Cell Therapeutics' Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive ...
Tags: marketing authorization, pharmaceutical product, Pixuvri
